MTRAX
Price
$21.01
Change
-$0.11 (-0.52%)
Updated
Feb 21 closing price
Net Assets
1.05B
RIRBX
Price
$72.48
Change
-$0.25 (-0.34%)
Updated
Feb 21 closing price
Net Assets
110.16B
Ad is loading...

MTRAX vs RIRBX

Header iconMTRAX vs RIRBX Comparison
Open Charts MTRAX vs RIRBXBanner chart's image
NYLI Income Builder
Price$21.01
Change-$0.11 (-0.52%)
VolumeN/A
Net Assets1.05B
American Funds Capital Income Bldr R2
Price$72.48
Change-$0.25 (-0.34%)
VolumeN/A
Net Assets110.16B
MTRAX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MTRAX vs. RIRBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTRAX is a StrongBuy and RIRBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 110B vs. MTRAX (1.05B). MTRAX pays higher dividends than RIRBX: MTRAX (2.86) vs RIRBX (2.55). MTRAX was incepted earlier than RIRBX: MTRAX (30 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. MTRAX (56.00). RIRBX has a lower initial minimum investment than MTRAX: RIRBX (250) vs MTRAX (15000). MTRAX annual gain was more profitable for investors over the last year : 14.05 vs. RIRBX (11.30). RIRBX return over 5 years is better than : 24.48 vs. MTRAX (18.94).
MTRAXRIRBXMTRAX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years23 years-
Gain YTD4.2954.98386%
Front LoadN/AN/A-
Min. Initial Investment150002506,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.05B110B1%
Annual Yield % from dividends2.862.55112%
Returns for 1 year14.0511.30124%
Returns for 3 years16.2911.93137%
Returns for 5 years18.9424.4877%
Returns for 10 years28.2231.5489%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KELYA13.870.18
+1.31%
Kelly Services
LRMR3.19-0.08
-2.45%
Larimar Therapeutics
EXPE196.81-8.33
-4.06%
Expedia Group
OSIS202.27-12.10
-5.64%
OSI Systems
SABS1.82-0.13
-6.67%
SAB Biotherapeutics